Gregory Fontana

Cardiac surgeon
Hospital Corporation of America a - Thousand Oaks, United States

Latest contributions

SPOTLIGHT: Standardised definitions for clinical and imaging endpoints after surgical and transcatheter valve intervention

In this presentation from PCR London Valves 2017, A. Baumbach, D. Capodanno, A. Lansky, M.B. Leon and N. Piazza focus on the durability, structural deterioration and valve failure, the neurological adverse events and on what really matters in clinical and patient-reported endpoints after surgical and transcatheter valve interventions.

Randomised trials of TAVI in intermediate-risk patients - Implications for everyday practice

25 Sep 2017 – From PCR London Valves 2017

LIVE demonstration from San Raffaele Scientific Institute Milan: percutaneous direct mitral annuloplasty

25 Sep 2017 – From PCR London Valves 2017

Portico - when expertise meets simplicity: key learnings

19 Sep 2016 – From PCR London Valves 2016

Chairperson

Gregory Fontana
Helge Moellmann

Chairperson

Helge Moellmann

Keynote lecture and round table discussion

18 Sep 2016 – From PCR London Valves 2016

Concluding remarks

18 Sep 2016 – From PCR London Valves 2016

Risk assessment: specialised techniques and strategies and vascular access

30 Sep 2014 – From PCR London Valves 2014

Chairperson

Gregory Fontana
Martine Gilard

Chairperson

Martine Gilard

TAVI: precise placement leads to optimal patient outcomes

29 Sep 2014 – From PCR London Valves 2014

Axel Linke

Chairperson

Axel Linke
Ganesh Manoharan

Chairperson

Ganesh Manoharan

Can an in-situ recapturable and repositionable TAVI platform influence procedural and patient outcome

21 May 2014 – From EuroPCR 2014

Ganesh Manoharan

Chairperson

Ganesh Manoharan